UNSPSC 51283416: Benzylpenicillin sodium

This classification denotes a penicillin antibiotic with the molecular formula C16H17N2O4S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YS5LY7JF4N, chemically known as penicillin, (phenylmethyl)- but more generally known as benzylpenicillin sodium, which bears US NIH Compound Identifier 2349. European Medicines Agency schedules Benzylpenicillin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13038MIG.

Most nations, for tariff and trade purposes, schedule benzylpenicillin sodium under HS 29411090. SMILES: CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3CCCCC3)C(=O)[O-])C.[NA+].

UNSPSC 51283416 Benzylpenicillin sodium is a Commodity code covering injectable antibiotic pharmaceuticals for procurement by state and local health agencies and emergency-response authorities. The recent opportunities under this code show state and local governments purchasing pharmaceutical supplies through piggyback contracts and direct competitive bidding to support public health initiatives, emergency preparedness, and community health programs. The Illinois Department of Public Health and Seminole County, Florida represent the issuing bodies active in this space, acquiring pharmaceutical products including antibiotics and ancillary medical supplies through established cooperative purchasing vehicles and Invitation for Bid processes.

Activity under the code is concentrated in the Midwest and Southeast, with documented recent procurement from Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, valued at $2,999,999.11 over 12 months with two renewal options, sourcing Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets through the MMCAP Infuse consortium. Seminole County, Florida solicited 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding with quarterly deliveries, though that opportunity closed on July 26, 2023. Both procurements emphasize electronic bidding submission, compliance with drug-free workplace and E-Verify requirements, and fixed-fee or unit-cost pricing models. Neither opportunity required formal set-asides for disadvantaged enterprises.